Is it true ? A buddy who is part of the JP-Morgan crowd told me that Acadia is seriously looking at buying Acorda and their inhaled levodopa.
It’s about bloody time. We need to expand our portfolio even if it is a me too product. Let’s build this company!
This is BS. We barely have $400 million dollars. We have to spend that money on our commercial expansions and ongoing clinical trials.
No, it isn't There are ways that Bankers can pull this M&A together. Plus SO MUCH SYNERGY of call-points. Pity if our BD folks are not thinking about this one.
One of my prescribing docs is very excited about Inbrija. He thinks it is going to be a super-winner. It be awesome if we get another product soon. I can see the great logic on buying Acorda
Let’s be real, this acquisition will have us selling a me too... just a different delivery. We know that we can’t rely on pipelines, so unless rHIgM22 breaks through strap in for an uneventful product.
Is not a me-too at all You know very little of the rescue of on-off READ and EDUCATE yourself before you speak
Clear that you don't know PD and the on-off unmet medical need. This will be a great product for us as a P2
Acadia is currently in a 3 month negotiation period with neuren pharmaceuticals for the rest of the world rights for trofinetide. Makes more sense they would buy out neuren.
Who ever said that doesn't know this business AT ALL! Every drug thats ever sold has a delivery system. THAT is a crucial part of development. The success of a product often times depends solely on its delivery system, even if its an older drug, a novel delivery system makes it new again. inbrija will be wildly successful IF the sales team is worth a salt.